Roche relents
the row over licensing of avian flu drug Tamiflu, has given a glimpse of how the issue of access to drugs will be handled, in future public health emergencies.
The Swiss pharma major, Roche, which has properietory rights over the drugs, had finally agreed to talk with generic drug manufacturers about producing a cheap version of Tamiflu